Status:
RECRUITING
Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Superficial Vein Thrombosis
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Superficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials...
Eligibility Criteria
Inclusion
- Patient over 18
- Patient affiliated to a social security scheme
- Patient who understands French
- Patient with superficial venous thrombosis of the lower and upper limbs confirmed by a Doppler ultrasound less than one month old.
- Patient with active cancer:
- Cancer treatment within the last 6 months,
- Detectable tumor disease, cancer treatment within the last 6 months, ongoing hormone therapy for cancer, palliative cancer.
- The patient has received potentially non-curative cancer treatment (notably palliative chemotherapy).
- Progression shows that the cancer treatment was not curative (due to recurrence or progression under treatment) (particularly in the case of recurrence after surgery)
Exclusion
- Patients under legal protection
- Patients with concomitant pulmonary embolism
- Patient with proximal or distal deep vein thrombosis
- Patient treated with anticoagulant therapy for another indication
- Patient with a contraindication to anticoagulation: Thrombocytopenia less than 30,000 elements/mm3, active bleeding or history of severe bleeding.
- Patient opposed to participation in research
Key Trial Info
Start Date :
November 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
1576 Patients enrolled
Trial Details
Trial ID
NCT07210671
Start Date
November 10 2025
End Date
November 1 2028
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480